Profile data is unavailable for this security.
About the company
Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products such as in vitro diagnostic reagents and supporting testing instruments. The Company's products mainly include vitro diagnostic reagents, supporting testing instruments and in vitro testing services. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. The Company's products are used in infectious disease prevention and control, clinical testing, large-scale population screening, eugenics management and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)339.03m
- Net income in CNY-25.96m
- Incorporated2010
- Employees592.00
- LocationJiangsu Bioperfectus Technologies Co LtdNo. 837, Yaocheng AvenueTAIZHOU 225300ChinaCHN
- Phone+86 52 380225599
- Fax+86 52 386201617
- Websitehttp://www.bioperfectus.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 842.11m | -479.50m | 5.01bn | 2.28k | -- | 0.787 | -- | 5.94 | -2.48 | -2.48 | 4.37 | 31.55 | 0.107 | 1.44 | 3.39 | 369,997.60 | -6.68 | 21.19 | -7.77 | 26.74 | 34.88 | 58.52 | -62.43 | 32.42 | 3.86 | -- | 0.0462 | 24.78 | 0.946 | 17.65 | -33.06 | -- | 138.80 | -- |
| Assure Tech (Hangzhou) Co Ltd | 462.72m | 120.87m | 5.04bn | 741.00 | 41.72 | 0.9768 | -- | 10.90 | 0.9511 | 0.9511 | 3.64 | 40.62 | 0.0809 | 2.22 | 2.17 | 624,449.30 | 2.11 | 23.69 | 2.30 | 28.01 | 30.32 | 64.61 | 26.11 | 47.65 | 11.28 | -- | 0.0012 | 18.78 | 7.42 | 20.85 | 35.85 | 28.69 | 63.16 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 433.83m | 125.95m | 5.42bn | 639.00 | 43.03 | 3.27 | -- | 12.49 | 1.32 | 1.32 | 4.53 | 17.31 | 0.2411 | 4.00 | 14.42 | 678,922.30 | 7.00 | 8.39 | 7.63 | 9.20 | 61.24 | 71.62 | 29.03 | 32.76 | 6.54 | -- | 0.0182 | 59.13 | -13.45 | 4.64 | -25.16 | 0.4474 | 39.73 | -- |
| Hangzhou Biotest Biotech Co Ltd | 478.69m | 102.57m | 5.44bn | 603.00 | 52.28 | 2.33 | -- | 11.36 | 0.6964 | 0.6964 | 3.06 | 15.66 | 0.1913 | 3.20 | 5.70 | 793,854.10 | 4.02 | 23.63 | 4.25 | 26.20 | 50.57 | 56.59 | 21.00 | 41.47 | 13.08 | -- | 0.00008 | 34.42 | 26.53 | 21.78 | 59.01 | 43.12 | 44.08 | -- |
| SWS Hemodialysis Care Co Ltd | 733.59m | 113.43m | 5.52bn | 1.10k | 48.84 | 3.13 | -- | 7.53 | 0.3538 | 0.3538 | 2.29 | 5.52 | 0.3577 | 2.80 | 6.23 | 665,688.20 | 5.23 | 5.68 | 5.83 | 6.54 | 45.71 | 45.79 | 14.61 | 16.06 | 5.25 | -- | 0.0014 | 28.46 | -17.80 | 31.86 | -63.55 | -- | 24.70 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 671.62m | -72.38m | 5.76bn | 1.22k | -- | 4.62 | -- | 8.57 | -0.5475 | -0.5475 | 5.10 | 9.25 | 0.3834 | 1.02 | 2.29 | 552,775.60 | -4.14 | 3.01 | -5.15 | 3.34 | 61.79 | 68.86 | -10.80 | 7.52 | 1.57 | -- | 0.2086 | 43.30 | 10.54 | 20.28 | -63.68 | -16.86 | 23.29 | -- |
| Qingdao NovelBeam Technology Co Ltd | 571.80m | 174.33m | 5.85bn | 841.00 | 33.62 | 4.44 | -- | 10.23 | 1.45 | 1.45 | 4.76 | 10.99 | 0.3817 | 0.9932 | 5.67 | 679,901.10 | 11.39 | 12.70 | 12.61 | 14.11 | 64.34 | 63.15 | 29.84 | 33.96 | 3.43 | 51.04 | 0.1058 | 40.95 | -5.90 | 11.86 | -7.11 | 13.48 | 13.44 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 339.03m | -25.96m | 5.88bn | 592.00 | -- | 1.98 | -- | 17.36 | -0.3096 | -0.3096 | 4.04 | 35.38 | 0.0903 | 1.85 | 6.13 | 572,683.70 | -0.6919 | 20.36 | -0.796 | 24.55 | 58.22 | 62.71 | -7.66 | 31.89 | 3.22 | -- | 0.1329 | 28.76 | -13.29 | 3.90 | 99.46 | -- | -9.88 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.05bn | 251.02m | 5.93bn | 1.67k | 23.41 | 2.82 | -- | 5.62 | 0.5907 | 0.5907 | 2.47 | 4.90 | 0.3855 | 2.51 | 5.74 | 631,202.60 | 8.98 | 14.03 | 12.10 | 17.34 | 61.03 | 62.46 | 23.30 | 27.25 | 3.00 | -- | 0.1406 | 39.01 | 0.2024 | 22.12 | 5.12 | 27.99 | -1.63 | 18.64 |
| Cowealth Medical China Co Ltd | 777.03m | -11.37m | 6.74bn | 203.00 | -- | 6.10 | -- | 8.67 | -0.0285 | -0.0285 | 1.97 | 2.78 | 0.5206 | 3.32 | 1.00 | 3,827,724.00 | -0.7168 | 4.75 | -0.9393 | 6.35 | 16.38 | 20.19 | -1.38 | 5.56 | 2.65 | -- | 0.0229 | 33.36 | -14.05 | -2.15 | -41.58 | -16.31 | 2.73 | -- |
Data as of Feb 11 2026. Currency figures normalised to Jiangsu Bioperfectus Technologies Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.45m | 2.93% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 620.00k | 0.74% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 136.16k | 0.16% |
| Xinyuan Asset Management Co., Ltd.as of 30 Jun 2025 | 127.55k | 0.15% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 98.99k | 0.12% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 36.36k | 0.04% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 30.15k | 0.04% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 22.43k | 0.03% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 22.32k | 0.03% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 21.07k | 0.03% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
